Coronary CT angiography is widely recognised as a reliable imaging modality for the diagnosis of coronary artery disease. Coronary CT angiography not only provides excellent visualisation of anatomical changes in the coronary artery with high diagnostic value in the detection of lumen stenosis or occlusion, but also offers quantitative characterisation of coronary plaque components. Furthermore, coronary CT angiography allows myocardial perfusion imaging with diagnostic value comparable to the reference standard method. Coronary CT angiographyderived haemodynamic analysis has the potential to evaluate functional significance of coronary lesions. This review article aims to provide an overview of clinical applications of coronary CT angiography in coronary artery disease.
Introduction
Coronary computed tomography angiography (CCTA) has become a routine imaging modality for the diagnosis of coronary artery disease (CAD) due to its high diagnostic accuracy, less invasiveness and wide availability. [1] [2] [3] [4] [5] Rapid developments in multislice CT scanning techniques have enabled the CCTA to be performed in a low-dose protocol with radiation dose similar to that of invasive coronary angiography. [6] [7] [8] Some recent studies have shown that radiation dose associated with CCTA can be further lowered to 0.1-0.4mSv, which is equivalent to that of routine chest radiography. 9, 10 In addition to the anatomical assessment of coronary lumen stenosis, CCTA allows for quantitative assessment of coronary plaque morphological features. This is clinically important as coronary lumen stenosis does not always translate to functional significance, as plaque components instead of degree of lumen stenosis play a critical role in predicting cardiac events and guiding patient management through identification of high-risk plaques. Furthermore, CCTA shows high diagnostic value in identifying myocardial ischaemic changes by providing functional assessment of CAD. Despite these promising outcomes, there are still some challenges to be resolved, especially the limited diagnostic value of CCTA in highly calcified plaques. This review article provides a comprehensive overview of the current developments of CCTA in CAD, with a focus on the diagnostic value and functional assessment of CCTA in CAD. Challenges of CCTA are discussed, and future directions are highlighted.
Diagnostic value of CCTA in CAD
CCTA has been confirmed as a reliable imaging modality in the diagnosis of CAD with high diagnostic accuracy. It is well known that the diagnostic performance of CCTA has been significantly improved from early generation of 4-slice CT to 64-and post 64-slice CT. This is mainly due to the improved spatial and temporal resolution of multi-slice CT scanners, which enable detection of coronary artery and its side branches with high resolution: isotropic spatial resolution of 0.4x0.4x0.4mm 3 , and temporal resolution of up to 75ms. The spatial resolution of current CCTA imaging technique is close to that of invasive coronary angiography (ICA), which is 0.2mm. 11 The newly introduced high-definition CT scanner with substantially improved in-plane spatial resolution of 0.23mm further improved diagnostic value of CCTA. 12 Pontone et al. compared the diagnostic value of high spatial resolution (0.23mm) with standard spatial resolution (0.625mm) CCTA in patients at high risk for CAD by using ICA as the reference method. 13 Their results showed that overall agreement between CCTA and ICA was significantly improved in the analysis of calcified coronary plaques for high resolution CCTA when compared to the standard CCTA.
The temporal resolution of current multi-slice CT scanners is still inferior to that of ICA, which is 10-20ms. 11 Hence, heart rate control is still necessary in most of the patients to ensure acquisition of cardiac CT images with acceptable diagnostic quality.
Currently, 64-slice CT has become a widely available technique in most of the public hospitals and private practices, while 128-, 256-and 320-slice CT scanners are also increasingly used in many clinical centres. Table 1 shows the diagnostic value of CCTA in CAD, according to several systematic reviews and meta-analyses of diagnostic value of CCTA with use of 64-slice and 320-slice scanners. [14] [15] [16] [17] [18] [19] [20] [21] [22] As shown in Table 1 , CCTA has high diagnostic sensitivity of more than 93 per cent and specificity of more than 86 per cent at per-patient assessment. It is well-known that CCTA has a very high negative predictive value (>95 per cent), thus it can be used as a gatekeeper to reliably exclude patients with suspected CAD.
Quantitative assessment of coronary plaques by CCTA
It has become well established that plaque composition is a key determinant of plaque stability. 23 Progressive increasing worldwide use of CCTA has demonstrated that CCTA has the potential to revolutionise how patients are risk-stratified by identifying rupture-prone, non-calcified or predominant non-calcified coronary plaques accurately and reliably. As our understanding of plaque histology has improved, there has been an increasing interest in the ability of CCTA to identify particularly the high-risk or vulnerable plaques. 24, 25 According to the SCCT (Society of Cardiovascular Computed Tomography) criteria of subdividing plaques into calcified, predominant calcified, non-calcified, predominant noncalcified and partially calcified types, CCTA shows excellent inter and intra-observer agreement, and high capability to quantify and distinguish plaque types.
26-30
Intravascular ultrasound (IVUS) is the gold standard for characterisation of coronary plaque composition. However, it is an invasive procedure which is not commonly performed in routine clinical practice and thus may be limited to research studies. CCTA as a less-invasive imaging modality has been reported to have comparable diagnostic value with IVUS in the assessment of plaque features. Studies based on head to head comparison between CCTA and IVUS reported the high diagnostic accuracy of CCTA with good correlation with IVUS for quantitative assessment of coronary plaques. 31 showed that CCTA is accurate for the quantification of coronary plaques with mean sensitivity and specificity being 93 per cent and 92 per cent to detect any plaque when compared to IVUS. Our experience of using 3D virtual intravascular endoscopy (VIE) for visualisation of coronary plaques has demonstrated the potential value of this novel technique for plaque characterisation and intraluminal appearances 36,37 ( Figure 1 ), although further studies should be conducted to correlate VIE findings with IVUS analysis. The reader is referred to some excellent reviewing articles on the CCTA in coronary plaque quantification.
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Functional assessment of CCTA in CAD
It is well known that anatomical coronary stenosis by CCTA is not necessarily associated with functional significance. 41 Therefore, detection of myocardial ischaemic changes caused by coronary plaques is more important than anatomical assessment of lumen stenosis since patients with decreased myocardial perfusion will benefit from revascularisation, thus, reducing adverse cardiac events. Myocardial CT perfusion imaging has been increasingly used in clinical practice with promising results reported based on single centre and multicentre experiences. On per-patient and per-vessel analysis, the sensitivity of myocardial CT perfusion imaging was significantly higher than that of SPECT, which was 88 per cent and 78 per cent, 62 per cent and 54 per cent (p<0.05), respectively. The specificity of SPECT imaging was significantly higher than that of CT perfusion imaging, which was 67 per cent and 81 per cent, 55 per cent and 62 per cent at per-patient and vessel analysis (p<0.05), respectively. The area under the receiver operating characteristic curve (AUC) for myocardial CT perfusion imaging was significantly higher than that for SPECT imaging at per-patient and per-vessel analysis, with corresponding values being 0.78 and 0.74, 0.69 and 0.69 (p<0.05), respectively. Despite these promising reports, SPECT, as the reference method for functional assessment of coronary stenosis is regarded as the first line diagnostic test for the diagnosis and prognosis of patients with CAD as there is insufficient evidence to recommend CCTA as the first line test. 48, 49 Table 2 compares the characteristics between myocardial perfusion SPECT and myocardial CT perfusion imaging in the diagnostic evaluation of CAD.
Recently, investigation of diagnostic performance of noninvasive fractional flow reserve (FFR) derived from CCTA (FFR CT ) has attracted a lot of interest. Computation of FFR CT is performed by computational fluid dynamics (CFD) modelling after segmentation of coronary arteries and left ventricular myocardium. Calculation of the FFR CT ratio is acquired by dividing the mean pressure distal to the coronary stenosis by the mean aortic pressure, and this can be measured during CFD simulations. An FFR of ≤0.80 is currently used as a cut off value to determine hemodynamic coronary stenosis responsible for myocardial ischemia (Figures 2 and 3 ).
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Clinical validation of FFR CT is based on a direct comparison to measured FFR during ICA. Currently, three multicentre trials are available in the literature, namely DISCOVER-FLOW DeFACTO and NXT trials investigating the diagnostic value of FFR CT in CAD. [52] [53] [54] The reported sensitivity and specificity of FFR CT ranged from 86-90 per cent to 54-79 per cent, on a per-patient analysis, while on a per-vessel analysis, the sensitivity and specificity of FFR CT ranged from 84 per cent to 86-88 per cent, respectively. Several systematic reviews and meta-analyses of FFR CT in comparison with CCTA with invasive FFR as the reference method also supported the statement that FFR CT was more accurate for diagnosing myocardial ischemia due to coronary lesions. [55] [56] [57] Despite these promising results of FFR CT in the detection of flowlimiting coronary stenosis, more multicentre trials need to be performed to compare the clinical impact of FFR CT guided-treatment versus standard diagnostic evaluation on clinical outcomes, costs and quality of life in patients with suspected coronary artery disease.
Challenges of CCTA and future directions
There are some limitations with CCTA which need to be addressed so that its clinical efficacy will be further enhanced. First, although CCTA allows a comprehensive assessment of coronary plaques regarding lumen changes and plaque characterization and composition, its ability to differentiate vulnerable or unstable plaques from those which are stable is still inferior to IVUS or optical coherence tomography. [58] [59] [60] [61] Therefore, differentiation of lipid-rich content from fibrous content with CCTA remains challenging due to considerable overlap in the attenuation values of lipid and fibrous tissue. Second, extensive coronary artery calcification (coronary calcium score >400) still limits the diagnostic accuracy of CCTA in CAD, in particular, reducing the sensitivity to some extent due to high rate of false positive results. It has been reported that highly calcified plaques (high calcium in the plaques) significantly lowered the specificity of CCTA to between 18 per cent and 44 per cent if no image post-processing was implemented. [62] [63] [64] [65] With use of iterative reconstruction (IR) and other image processing algorithms, the specificity and positive predictive values (PPV) were improved due to suppressing the blooming artefacts from high calcium scores. [66] [67] [68] [69] Although IR has been confirmed to significantly reduce radiation dose and improve image quality when compared to the conventional image reconstruction of filtered back projection in CCTA, most recent studies have shown the negative impact of IR techniques on coronary artery calcium scores which could change patient's risk stratification in up to 31 per cent patients. [70] [71] [72] Thus, use of image processing algorithms could be an effective approach for diagnostic assessment of calcified coronary plaques. This is confirmed by our recent study with specificity and positive predictive value significantly improved for CCTA diagnosis of calcified plaques when compared to the conventional approach (66 per cent and 57 per cent vs. 33 per cent and 41 per cent for CCTA with and without use of image processing) ( Figure  4 ). 68 Despite these improvements, the specificity is still moderate, and more studies are needed to further enhance CCTA diagnostic performance. Another approach to improve diagnostic performance of CCTA in calcified plaques is to use the high definition CT scanner with substantially improved in-plane spatial resolution of 0.23 mm, therefore, reducing beam hardening and blooming artefacts due to heavy calcification in coronary plaques. 12 Pontone et al. reported that at a segment-based analysis, the specificity and PPV were 98 per cent and 91 per cent for high resolution CCTA, which is significantly higher than the 95 per cent and 80 per cent for standard CCTA (0.625 mm spatial resolution). Significant improvement was found with high resolution CCTA in the analysis of calcified plaques when compared to the standard CCTA, 13 although further studies are needed to confirm its clinical value.
Clinical applications of CCTA in CAD have undergone a paradigm shift from test performance to assessment of end clinical outcomes. This is represented by some randomised controlled trials available in the recent literature, including FACTOR-64 Randomized Clinical Trial, PROMISE Clinical Trial, PLATFORM Clinical Trial and SCOT-HEART trial. [73] [74] [75] [76] Table 3 summarises key findings of these four multicentre trials. As shown in the table, clinical value of CCTA is controversial as FACTOR-64 and PROMISE trials concluded that CCTA did not improve clinical outcomes as compared with functional testing or did not reduce all-cause mortality. While in the SCOT-HEART trial, CCTA was found to change treatment strategy which was associated with reduction in fatal and non-fatal myocardial infarction. According to the PLATFORM Trial, authors concluded that use of CCTA/FFR CT can be more effectively triage patients than the use care approach for invasive procedures since ICA was cancelled in 61 per cent of patients based on the results of CCTA/FFR CT.
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Summary and conclusion
Coronary CT angiography has developed as reliable lessinvasive imaging modality in the diagnosis of coronary artery disease. Tremendous progress has taken place over the last decades in cardiac CT imaging, owing to the evolution of CT scanning technology, which allows coronary CT angiography to serve as a potential alternative to invasive coronary angiography. In addition to anatomical assessment of coronary lumen stenosis and quantification of coronary plaques, functional evaluation of significance of coronary stenosis is also improving which is manifested by promising results of myocardial CT perfusion imaging. Coronary CT angiography-derived haemodynamic studies and FFR CT shows improved clinical outcomes in the diagnostic evaluation of patient-specific lesions. Multicentre trials have confirmed the clinical value of coronary CT angiography for reduction of cardiac mortality and improvement of patient outcomes, although more studies based on long-term follow-up are required to further validate its clinical applications. With more research being conducted using advanced cardiac CT imaging techniques, there is no doubt that coronary CT angiography continues to play an important role in the early detection and diagnosis of coronary artery disease and prevention of major adverse cardiac events through improving treatment strategy. 
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